We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Brain tumour research in the UK to receive £45 million in funding from the Department of Health and Social Care and Cancer Research UK.
First published during the 2016 to 2019 May Conservative government
Recombinant human erythropoietin (r-HuEPO) treatment has been associated with very rare cases of life-threatening severe cutaneous adverse reactions (SCARs), including Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). Withdraw r-HuEPOs permanently in patients who develop severe skin reactions such as...
Risk of meningioma with cyproterone acetate increases with increasing cumulative dose. Use of cyproterone is contraindicated in patients with previous or current meningioma (for all indications) and should only be considered for control of libido in severe hypersexuality or paraphilias...
The funding is double the original amount and will be used to encourage new research and clinical practice to improve outcomes for people with brain tumours.
Monitoring technology takes just a finger prick to carry out a blood test count that helps chemotherapy patients to manage their treatment.
Dental examination and appropriate preventive dentistry should be considered before treatment with bevacizumab or sunitinib.
Perform a quantitative serum anti-JCV antibody test—including index value—to support risk stratification for progressive multifocal leukoencephalopathy. For high-risk patients, consider more frequent MRI screening.
Improvements to the Work Capability Assessment will mean more people suffering from cancer will get the unconditional help they need.
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
More being done to improve earlier diagnosis shows research by PHE’s National Cancer Intelligence Network (NCIN).
Risk of developing progressive multifocal leukoencephalopathy (PML) associated with natalizumab is increased in patients who have had previous immunosuppressant therapy.
The government’s first ever cancer campaign to increase awareness of bowel cancer is to be rolled out nationally.
Up to £250 million invested in bringing advanced radiotherapy treatment to UK.
Dental examination and appropriate preventive dentistry should be considered before treatment, especially for patients also treated with an intravenous bisphosphonate.
Letter from Professor Sir Bruce Keogh, NHS Medical Director, outlining plans for improving cancer survival rates through earlier diagnosis.
Severe skin reactions such as Stevens-Johnson syndrome and toxic epidermal necrolysis have been reported during treatment with capecitabine.
New safety recommendations have been issued while an EU review evaluates cases of neural tube defects in babies born to mothers who became pregnant while taking the HIV medicine dolutegravir.
Employment Tribunal decision.
Consultation on reforming the Work Capability Assessment.
Organisations can apply for a share of £425,000 to develop new ways of using existing data to improve cancer care in Scotland.
Consider progressive multifocal encephalopathy (PML) in the differential diagnosis for patients with new or worsening neurological signs or symptoms, even several years after treatment with cladribine.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).